Researchers ask: does extra support help lung disease patients?
NCT ID NCT06912659
Summary
This study is observing patients in Spain who have pulmonary fibrosis and are taking the medication nintedanib. The goal is to see how satisfied they are with a special support program and to monitor their quality of life, symptoms, and medication use over one year. It is not testing a new treatment, but aims to understand the value of the support program itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Evidenze Health Espana S.L.
Barcelona, 08005, Spain
Conditions
Explore the condition pages connected to this study.